{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "PARK7 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper defines DJ-1's role in neurodegeneration through interaction with TTRAP, affecting apoptosis pathways.",
          "judgment": "Yes",
          "reasoning": "Clear mechanism involving DJ-1 and TTRAP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay classes",
          "extracted_paper_info": "Yeast two-hybrid and cell assays were used to assess binding and protective effects.",
          "judgment": "Yes",
          "reasoning": "Assays model disease pathogenesis."
        },
        {
          "step_name": "Step 3a: Basic Controls/Replicates",
          "extracted_paper_info": "Wild-type controls used, but replicates not detailed.",
          "judgment": "No",
          "reasoning": "Insufficient details on replicates and variant controls."
        },
        {
          "step_name": "Step 3b: Accepted Assay",
          "extracted_paper_info": "Standard methods like yeast two-hybrid are established.",
          "judgment": "Yes",
          "reasoning": "Assays are broadly accepted in the field."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "M26I mutation disrupts TTRAP-mediated protection, supporting pathogenicity with moderate evidence."
    },
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "PARK7 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "DJ-1 interacts with TTRAP, influencing cell survival via JNK and p38-MAPK pathways.",
          "judgment": "Yes",
          "reasoning": "Mechanism is clearly defined."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay classes",
          "extracted_paper_info": "Cell assays demonstrated apoptosis induction by mutants.",
          "judgment": "Yes",
          "reasoning": "Assays reflect disease mechanism."
        },
        {
          "step_name": "Step 3a: Basic Controls/Replicates",
          "extracted_paper_info": "Wild-type and mutant controls were used, but replicates details unclear.",
          "judgment": "No",
          "reasoning": "Lack of detailed replicate information."
        },
        {
          "step_name": "Step 3b: Accepted Assay",
          "extracted_paper_info": "Standard cell assays are widely accepted.",
          "judgment": "Yes",
          "reasoning": "Assays are validated in research."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "L166P mutation impairs TTRAP function, supporting pathogenicity with moderate evidence."
    }
  ]
}